Gilead Sciences
GILD
£81.07
Share price
0.46%
Change (1 day)
45.04%
Change (1 year)
Categories
Gilead Sciences (GILD) - Total assets
Total assets on the balance sheet as of March 2025 : £42.16 Billion
According to Gilead Sciences's latest financial reports the company's total assets are £42.16 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Gilead Sciences - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | £47.01 B | -3.59% |
| 2023-12-31 | £48.76 B | -6.61% |
| 2022-12-31 | £52.21 B | 3.72% |
| 2021-12-31 | £50.34 B | 0.31% |
| 2020-12-31 | £50.18 B | 6.79% |
| 2019-12-31 | £46.99 B | -6.31% |
| 2018-12-31 | £50.16 B | -3.54% |
| 2017-12-31 | £52.00 B | 12.62% |
| 2016-12-31 | £46.17 B | 32.32% |
| 2015-12-31 | £34.89 B | 56.74% |
| 2014-12-31 | £22.26 B | 62.65% |
| 2013-12-31 | £13.68 B | 4.16% |
| 2012-12-31 | £13.14 B | 18.04% |
| 2011-12-31 | £11.13 B | 48.24% |
| 2010-12-31 | £7.50 B | 25.3% |
| 2009-12-31 | £5.99 B | 26.63% |
| 2008-12-31 | £4.73 B | 61.15% |
| 2007-12-31 | £2.93 B | 40.8% |
| 2006-12-31 | £2.08 B | -4.49% |
| 2005-12-31 | £2.18 B | 94.48% |
| 2004-12-31 | £1.12 B | 29.21% |
| 2003-12-31 | £0.86 B | 8.18% |
| 2002-12-31 | £0.80 B | 46.56% |
| 2001-12-31 | £0.54 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | £66.77 B | 58.36% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | £17.09 B | -59.46% | 🇺🇸 USA |
 AbbVie ABBV | £101.74 B | 141.28% | 🇺🇸 USA |
 Illumina ILMN | £4.61 B | -89.05% | 🇺🇸 USA |
 Biogen BIIB | £20.94 B | -50.33% | 🇺🇸 USA |
 Pfizer PFE | £155.44 B | 268.62% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £144.71 B | 243.18% | 🇺🇸 USA |
 Eli Lilly LLY | £66.79 B | 58.40% | 🇺🇸 USA |
 Merck MRK | £86.02 B | 103.99% | 🇺🇸 USA |